Current News

/

ArcaMax

Shire sells cancer drugs to Servier as Takeda circles

on

Published in Current News Videos

Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion. As Pascale Davies reports, the deal suggests there is value locked up within Shire's portfolio - despite a dismal share price performance in the past two years.

 

Comments

blog comments powered by Disqus

Social Connections

Comics

Rhymes with Orange Mallard Fillmore Poorly Drawn Lines Andy Capp Archie Ginger Meggs